Navigation Links
Aridol in Medical News

Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test)

...n important underlying component of asthma." aridol will be a standardized test kit containing proprie...sing a proprietary hand-held inhaler. The goal of aridol is to provide physicians and health care professio...d Stephen Beckman, President, Pharmaxis, Inc. aridol is approved for sale in Australia, major European ...

Pharmaxis to Expand Manufacturing Capacity

...iratory and immune disorders. Its development pipeline of products include: aridol for the management of asthma, Bronchitol for cystic fibrosis, bronchiectasi...initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media re...
Aridol in Medical Technology

Pharmaxis Reports Phase II Results for Aridol in COPD

SYDNEY, Australia, March 14, 2007 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis today announced the results from its Phase II trial for Aridol in subjects with Chronic Obstructive Pulmonary Disease (COPD), a respiratory disease affecting over 30 million people worldwide. The ...

Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

...iratory and immune disorders. Its development pipeline of products includes aridol for the diagnosis of asthma, Bronchitol for cystic fibrosis, bronchiectasis...initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media re...

Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Announces New Drug Application Submission for Aridol(TM)

...ternational randomized pivotal Phase 3 trials with aridol involving over 1,000 subjects. The NDA applic...bronchial challenge test available in the U.S. and aridol is the first test of this kind that comes complete...s a substantial impact on the health of a nation. aridol was developed to assist with improving existing ma...

ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Bronchitol Cystic Fibrosis Dose Trial Results Positive

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...
Aridol in Biological Technology

Pharmaxis Aridol Approved for Sale in Switzerland

SYDNEY, Australia, Oct. 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that it had received approval to market Aridol from the Swiss therapeutic regulatory agency Swissmedic. Aridol is indicated for measuring airway hyperresponsi...

Pharmaxis' Aridol Authorised for Sale in Germany

SYDNEY, Australia, May 18 /Xinhua-PRnewswire-Firstcall/ -- Specialist Pharmaceutical Company Pharmaxis Ltd (ASX: PXS; Nasdaq: PXSL) today announced that it has received national approval to market Aridol in Germany. Aridol is indicated for measuring airway hyperresponsiveness and has been ap...

Pharmaxis' Aridol Gains First Asian Approval

SYDNEY, Jan. 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the Korean regulatory agency has granted marketing approval for its asthma management product, Aridol. "This is the first Asian approval of Aridol," said Pharmaxis Chief Executive Officer Dr A...

Pharmaxis Appoints Portuguese Distributor for Aridol

SYDNEY, Australia, Dec. 14 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the appointment of Pulmocor SA to market and distribute its asthma diagnostic tool, Aridol in Portugal. "Portugal was one of the 13 European countries included in the successful mut...

Pharmaxis Closes Share Purchase Plan

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Announces Placement of $47 Million and Share Purchase Plan

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, an...

U.S. FDA Accepts Aridol(TM) New Drug Application for Review

...ber 2009. Pharmaxis is seeking approval for aridol for "the assessment of bronchial hyperresponsivene...ual economic cost of $19.7 billion. When approved, aridol will be the first dry powder bronchial challenge t...rking with the FDA to complete the review." aridol is approved for sale in most major European countr...

New Pharmaxis Board Appointment

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Appoints French Distributor for Aridol(TM)

...raxis on developing the French market for Aridol. aridol is a precisely engineered test that we believe will be an improvement on current practice. aridol improves the identification of bronchial hyperresp...ian that has previously not been available. aridol is approved for sale in most major European countr...
Other Tags
(Date:4/20/2014)... of cell in the lining of the bladder is ... to researchers at the Stanford University School of Medicine. ... to pinpoint the normal cell type that can give ... to show that most bladder cancers and their associated ... why many human bladder cancers recur after therapy. , ...
(Date:4/18/2014)... medical-testing device is being prepped to enter the ... diagnosis of certain diseases in remote areas, thanks ... of investigations aboard the International Space Station on ... space-tested concept of capillary flow to diagnose infectious ... Kelso, Ph.D., a researcher at Northwestern University in ...
(Date:4/18/2014)... neuroscientists have made a discovery that turns 160 years ... insulating material long known to be essential for the ... cells, is not as ubiquitous as thought, according to ... the Harvard Stem Cell Institute (HSCI) and the University,s ... with Professor Jeff Lichtman, of Harvard,s Department of Molecular ...
(Date:4/18/2014)... did it make you feel? According to psychologists, remembering ... as how sad you were or how embarrassed you ... can,t stop thinking about it. , When these ... the memories, rather than how you felt, is a ... effects of these memories, a new study suggests. , ...
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
Breaking Medicine News(10 mins):Health News:Stanford scientists identify source of most cases of invasive bladder cancer 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 3Health News:Stanford scientists identify source of most cases of invasive bladder cancer 4Health News:Stanford scientists identify source of most cases of invasive bladder cancer 5Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:Scientists discover brain's anti-distraction system 2
(Date:4/17/2014)... one per eight hundred births, Down syndrome - or ... of intellectual disability. It results from a chromosomal abnormality ... of chromosome 21 (1% of the human genome). A ... the Department of Genetic Medicine and Development at the ... Nature , shed light on how the extra ...
(Date:4/17/2014)... House honored Clemson professor Rajendra Singh Thursday as ... promote and expand solar deployment in the residential, ... Houser Banks Professor of Electrical and Computer Engineering ... is considered a local hero leading the charge ... opportunity in solar power and driving policy changes ...
(Date:4/17/2014)... are implicated in many serious conditions such as heart ... target for drug therapies. Unfortunately, there is still much ... research provides fresh and unexpected insight into the structure ... - β-subunit molecules - which are responsible for ,fine-tuning, ... in the most recent edition of the Journal ...
Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2
Other Contents